A simple and cost-effective q EEG evaluation shows marked differences between early Alzheimer’s disease patients and controls thumbnail
Pause
Mute
Subtitles not available
Playback speed
0.25
0.5
0.75
1
1.25
1.5
1.75
2
Full screen

A simple and cost-effective q EEG evaluation shows marked differences between early Alzheimer’s disease patients and controls

Published on Oct 01, 20151326 Views

Due to population ageing prevalence of Alzheimer’s disease is expected to rise, therefore early diagnosis is paramount. Currently, AD diagnosis relies largely on clinical presentation and exclusion of

Related categories

Chapter list

A simple and cost-effective qEEG evaluation shows marked differences between early Alzheimer’s disease patients and controls00:00
Content00:35
Alzheimer's disease01:11
Why do early diagnosis of ad?01:58
Disorders of the brain and economic burdon03:10
Why consider eeg as biomarker for ad?03:41
Some reported effects of ad on eeg04:30
Objective05:07
Methodology - 106:13
Methodology - 206:51
Absolute scale07:27
Peak alpha frequencies07:52
Discriminatory potential?09:19
The jama network10:02
Limitations of currently presented work10:39
Take home messages11:47
Sources12:34
Thank you for your attention12:36